Westminster, CO (PRWEB) January 29, 2014
Neuromonics, Inc., is introducing an easy-to-use device to help tinnitus sufferers manage symptoms on demand.
The Neuromonics Haven™ is the company’s newest product to help individuals suffering from tinnitus, the condition often described as buzzing, ringing, hissing, humming, roaring, whistling or “ringing in the ears” that someone hears in the absence of any external sound. Globally, tinnitus affects an estimated 10-15 percent of the population. In the United States alone, more than 50 million people suffer from the condition, according to the American Tinnitus Association.
The Haven blends an individualized, high-frequency signal with relaxing music to provide patients an on-demand sense of control and relief while wearing the device. The new product is available by prescription, and programmed by an audiologist for a patient’s individual audiogram. With the ability to do in-office fittings, a patient can start to experience relief almost immediately, says Curtis Amann, vice president of marketing and sales for Neuromonics.
The Haven is not a masking device, explains Amann. Rather, the management tool works to promote new neural connections that allow the brain to help filter out the tinnitus perception while also breaking the negative limbic system attachment the body has to the tinnitus perception. Features include:
- Individualized spectral profile.
- Programmable via NOAH interface (industry-standard software platform for hearing device fitting).
- Balance control to help deal with asymmetries.
- Ability to regulate the neural stimulus volume.
The Haven serves as a step between Neuromonics’ Oasis™ and Sanctuary™ devices. The Oasis is the FDA-cleared, patented and clinically proven device that offers long-term treatment and significant relief for severe tinnitus. The Sanctuary functions in a similar manner as the Haven, providing situational relief, but works with a choice of pre-programmed profiles rather than individualized spectral profiles. All three Neuromonics devices are simple to use, functioning much like familiar consumer music players.
Full-service tinnitus company
“With the addition of the Haven to the product line, Neuromonics is providing effective treatment for the full range of those dealing with tinnitus – from those with severe symptoms to those needing only situational relief,” says Amann. “Delivering proven technology and treatment for the entire spectrum of tinnitus patients speaks to Neuromonics’ emergence as a full-service tinnitus company.”
The growing product portfolio is particularly important for members of the military, continues Amann. Usually brought on by exposure to loud noise, tinnitus – often referred to as “ringing in the ears” – is especially significant in the military. More than 34 percent of returning veterans from Iraq and Afghanistan suffer from the condition and, while there is no tinnitus cure, are seeking relief. Neuromonics developed the Haven with funds received from a U.S. Army Medical Research Acquisition Act. “With the Haven, Neuromonics now can provide treatment for the full range of tinnitus that particularly affects those who have served their country,” says Amann.
Neuromonics, Inc. (http://www.neuromonics.com)
Based in Westminster, Colo., Neuromonics, Inc., manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus. The patented and clinically proven Oasis, working the Neuromonics Tinnitus Treatment, provides long-term treatment and significant relief for those with severe tinnitus. The Haven, with the ability to program and individualize hearing profiles, is a management tool offering situational relief for tinnitus symptoms. The Sanctuary, also a management tool, works with pre-programmed profiles for on-demand relief.
With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. More than 400 licensed, trained audiologists across four continents administer the Neuromonics Tinnitus Treatment. Neuromonics news includes segments on national media including “The Doctors” and CNN.
This research and development project will be conducted by Neuromonics, Inc., and is made possible by a contract that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD, under Contract Number: W81XWH-11-2-0190.